Cargando…

Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea

Mostrar otras versiones (1)

BACKGROUND: Cervical cancer is a prevalent malignancy that is a major health problem for women worldwide. The cancer-preventive properties of metformin are well-known, but insufficient data have been reported regarding its relationship to cervical cancer. Therefore, in a nationwide population-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun Min, Kang, Min Jin, Song, Sun Ok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816509/ https://www.ncbi.nlm.nih.gov/pubmed/36604960 http://dx.doi.org/10.3803/EnM.2022.1613

Ejemplares similares

Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea
por: Kim, Hyun Min, et al.
Publicado: (2023)

Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea
por: You, Ji Hong, et al.
Publicado: (2020)

Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin
por: Aghili, Rokhsareh, et al.
Publicado: (2014)

Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes
por: Ji, Ming, et al.
Publicado: (2016)

Comparison of Safety and Efficacy of Glimepiride-Metformin and Vildagliptin- Metformin Treatment in Newly Diagnosed Type 2 Diabetic Patients
por: Kumar, Surendra
Publicado: (2021)

Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin
por: Hu, Yun, et al.
Publicado: (2021)

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
por: Liu, Jia, et al.
Publicado: (2017)

Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes
por: Seghieri, Marta, et al.
Publicado: (2018)

Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
por: Song, Lulu, et al.
Publicado: (2021)

The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus
por: Heo, Eunyoung, et al.
Publicado: (2021)

Assessment of vitamin B(6) status in Korean patients with newly diagnosed type 2 diabetes
por: Ahn, Hee Jung, et al.
Publicado: (2011)

Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
por: Hao, Zirui, et al.
Publicado: (2022)

MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
por: Wang, Na, et al.
Publicado: (2018)

The Effects of Gliclazide, Metformin, and Acarbose on Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus()
por: Wang, Hua, et al.
Publicado: (2013)

MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients
por: Wang, Guang, et al.
Publicado: (2014)

Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes
por: Shi, Chunhong, et al.
Publicado: (2019)

Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Shin, Min Young, et al.
Publicado: (2016)

Association of metformin use with Alzheimer’s disease in patients with newly diagnosed type 2 diabetes: a population-based nested case–control study
por: Ha, Junghee, et al.
Publicado: (2021)

Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus
por: Mu, Xiaodie, et al.
Publicado: (2023)

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)

Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial
por: Pan, Qingrong, et al.
Publicado: (2016)

Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective
por: Ji, Linong, et al.
Publicado: (2020)

DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes
por: Qiu, Min, et al.
Publicado: (2020)

Depression in newly diagnosed type 2 diabetes
por: Yu, Ruan, et al.
Publicado: (2010)

Thyroid autoimmunity in children and adolescents with newly diagnosed type 1 diabetes mellitus
por: Jung, Eui Seok, et al.
Publicado: (2014)

Cardiovascular risk in newly diagnosed type 2 diabetes patients in India
por: Unnikrishnan, A. G., et al.
Publicado: (2022)

Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Yoo, Soon-Jib, et al.
Publicado: (2021)

The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case–Control Study
por: Hu, Yanjin, et al.
Publicado: (2018)

Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria
por: Pan, Qingrong, et al.
Publicado: (2018)

Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients
por: Elbere, Ilze, et al.
Publicado: (2020)

Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion
por: Das, Ashok K., et al.
Publicado: (2021)

Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
por: Kong, Doo-Sik, et al.
Publicado: (2016)

Metformin use and cervical cancer risk in female patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2016)

Comparison of Health Outcomes by Care Provider Type for Newly Diagnosed Mild Type 2 Diabetes Patients in South Korea: A Retrospective Cohort Study
por: Kang, Hee-Chung, et al.
Publicado: (2022)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Effects of smoking habit change on all-cause mortality and cardiovascular diseases among patients with newly diagnosed diabetes in Korea
por: Cho, Mi Hee, et al.
Publicado: (2018)

A Nationwide Survey of Lymphangioleiomyomatosis in Korea: Recent Increase in Newly Diagnosed Patients
por: Park, Hye Yun, et al.
Publicado: (2010)

Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
por: Mo, Dan, et al.
Publicado: (2019)

Newly Diagnosed Type 1 Diabetes in an Elderly Patient
por: Cosme, Inês, et al.
Publicado: (2023)

Characteristics of recent HIV infection among individuals newly diagnosed as HIV-positive in South Korea (2008–2015)
por: Yoo, Myeongsu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pi35rdb4tafro4d7njvk2j0ihh